Skip navigation
Universidade Federal da Bahia |
Repositório Institucional da UFBA
Use este identificador para citar ou linkar para este item: https://repositorio.ufba.br/handle/ri/42694
Registro completo de metadados
Campo DCValorIdioma
dc.creatorFontes, Jonathan Luís Magalhães-
dc.date.accessioned2025-08-08T16:18:25Z-
dc.date.available2025-08-08T16:18:25Z-
dc.date.issued2024-07-10-
dc.identifier.citationFONTES, Jonathan Luís Magalhães. LXPLEEN: estudo dos genes e células envolvidas com a desorganização esplênica na leishmaniose visceral recidivante. Orientador: Washington Luis Conrado dos Santos. 2024. 73 f. Tese (Doutorado em Patologia Humana e Experimental) - Faculdade de Medicina da Bahia, Universidade Federal da Bahia; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador (BA), 2024.pt_BR
dc.identifier.urihttps://repositorio.ufba.br/handle/ri/42694-
dc.description.abstractBACKGROUND: Visceral leishmaniasis (VL) is a neglected zoonosis that has considerable impacts on public health. One of the problems related to VL is the emergence of severe forms that lead to the death of 6-8% of patients, even during treatment. In addition, some patients develop a recurrent form, with the occurrence of multiple returns to the hospital in a brief period. The spleen is a lymphoid organ responsible for hemocateresis and immunological surveillance and it engages in pathogenesis of VL, presenting disorganization of the white pulp (WP) and extensive replacements of the normal cellularity of the red pulp (RP) by plasma cells. Despite this, little is known about the contribution of splenic disruption in human VL and how changes in splenic cellularity change the profile of cytokine production in the organ, favoring susceptibility to infection. AIM: Our objective is to define which cells and signaling pathways participate in the disruption of splenic compartments and what is the association with progression in relapsed VL. MATERIAL AND METHODS: Using spleens from 6 patients with relapsed VL and 5 control patients, we performed immunohistochemistry to evaluate the distribution and relationship of leukocytes (T and Treg lymphocytes, B lymphocytes, macrophages and plasma cells) and cytokines (IL1B, IL4, IL6, IL10, IL17, IFNγ, TNF and TGF) in the WP and RP of the spleen. Furthermore, were performed the gene expression analysis and identification of DEG profiles and gene interaction networks involved with relapsing VL. RESULTS: There is an accumulation of macrophages and plasma cells in the RP of patients with VL, with reduced apoptosis and expression of genes related to lymphocyte migration; There is increased expression of BCL10 and ICOSLG; The IL6 signaling pathway is overexpressed in VL patients, and there is an increase in the amount of total IL6 and a negative correlation between IL6 and splenic WP percentage; There is negative correlation between the number of circulating leukocytes and the number of splenic leukocytes. CONCLUSIONS: In patients with recurrent VL, there is an accumulation of cells in the spleen mediated by reduced apoptosis and cell migration, corroborating to hypersplenism. Furthermore, the IL6 signaling pathway contributes to spleen disorganization.pt_BR
dc.description.sponsorshipCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)pt_BR
dc.languageporpt_BR
dc.publisherUniversidade Federal da Bahiapt_BR
dc.rightsAcesso Abertopt_BR
dc.subjectLeishmaniose visceral recidivantept_BR
dc.subjectPopulação leucocitáriapt_BR
dc.subjectBaçopt_BR
dc.subjectVia de sinalização IL6pt_BR
dc.subject.otherVisceral leishmaniasis relapsept_BR
dc.subject.otherLeukocyte populationpt_BR
dc.subject.otherSpleenpt_BR
dc.subject.otherIL6 signalingpt_BR
dc.titleLXPLEEN: estudo dos genes e células envolvidas com a desorganização esplênica na leishmaniose visceral recidivantept_BR
dc.title.alternativeLXPLEEN: study of genes and cells involved in splenic disorganization in relapsing visceral leishmaniasispt_BR
dc.typeTesept_BR
dc.publisher.programPós-Graduação em Patologia Humana e Patologia Experimental (PGPAT) pt_BR
dc.publisher.initialsUFBApt_BR
dc.publisher.countryBrasilpt_BR
dc.subject.cnpqCiências Biológicaspt_BR
dc.contributor.advisor1Santos, Washington Luis Conrado dos-
dc.contributor.advisor1IDhttps://orcid.org/0000-0002-5075-1254pt_BR
dc.contributor.advisor1Latteshttp://lattes.cnpq.br/9255856779100547pt_BR
dc.contributor.referee1Araújo, Iguaracyra Barreto de Oliveira-
dc.contributor.referee1Latteshttp://lattes.cnpq.br/0665150373328780pt_BR
dc.contributor.referee2Fullam, Juliana Perrone Bezerra de Menezes-
dc.contributor.referee2IDhttps://orcid.org/0000-0002-9380-8839pt_BR
dc.contributor.referee2Latteshttp://lattes.cnpq.br/2470641914861227pt_BR
dc.contributor.referee3Farias, Leonardo Paiva-
dc.contributor.referee3IDhttps://orcid.org/0000-0001-5717-5627pt_BR
dc.contributor.referee3Latteshttp://lattes.cnpq.br/7631998858401687pt_BR
dc.contributor.referee4Damasceno, Karine Araújo-
dc.contributor.referee4IDhttps://orcid.org/0000-0003-2087-1690pt_BR
dc.contributor.referee4Latteshttp://lattes.cnpq.br/2116784879155217pt_BR
dc.contributor.referee5Santos, Washington Luis Conrado dos-
dc.contributor.referee5IDhttps://orcid.org/0000-0002-5075-1254pt_BR
dc.contributor.referee5Latteshttp://lattes.cnpq.br/9255856779100547pt_BR
dc.creator.IDhttps://orcid.org/0000-0001-5717-5627pt_BR
dc.creator.Latteshttp://lattes.cnpq.br/5371830734677410pt_BR
dc.description.resumoINTRODUÇÃO: A leishmaniose visceral (LV) é uma zoonose negligenciada e que tem impactos consideráveis na saúde pública. Um dos problemas relacionado à LV é o surgimento de formas graves que leva ao óbito de 6-8% dos pacientes mesmo na vigência de tratamento. Além disso, alguns pacientes desenvolvem uma forma recidivante, com a ocorrência de múltiplos retornos ao hospital em curto período. O baço, um órgão linfoide responsável pela hemocaterese e vigilância imunológica, é afetado na LV apresentando desorganização da polpa branca (PB) e extensa substituição da celularidade normal da polpa vermelha (PV) por plasmócitos. Apesar disso, pouco se sabe a respeito da contribuição da desestruturação esplênica na LV humana e como e as mudanças na celularidade esplênica mudam o perfil de produção de citocinas no órgão favorecendo a susceptibilidade à infecção. OBJETIVO: Nosso objetivo é definir quais as células e vias de sinalização estão envolvidas na desestruturação dos compartimentos esplênicos e qual a provável associação com a progressão na LV recidivante. MATERIAL E MÉTODOS: Utilizando baços de 6 pacientes com LV recidivante e 5 pacientes controle, realizamos imuno-histoquímica para avaliar a distribuição e a relação de leucócitos (Linfócitos T e Treg, Linfócitos B e Macrófagos) e citocinas (IL1B, IL4, IL6, IL10, IL17, IFN, TNF e TGF) nos compartimentos de PB e PV do baço. Além disso, foi feita análise da expressão gênica e identificação de perfis de DEG e redes de interação gênica envolvidas com a LV recidivante. RESULTADOS: Há acúmulo de macrófagos e plasmócitos na PV de pacientes com LV, com redução de apoptose e da expressão de genes relacionados à migração de linfócitos; Há aumento da expressão de BCL10 e ICOSLG; A via de sinalização de IL6 está super-expressa nos pacientes com LV, e há aumento da quantidade de IL6 total e correlação negativa entre IL6 e porcentagem de PB esplênica; Há correlação negativa entre número de leucócitos circulantes e número de leucócitos esplênicos. CONCLUSÕES: Nos pacientes com LV recidivante ocorre acúmulo de células no baço mediado pela redução de apoptose e migração de células, corroborando para o hiperesplenismo. Além disso, a via de sinalização por IL6 contribui para a desorganização do baço.pt_BR
dc.publisher.departmentFaculdade de Medicina da Bahiapt_BR
dc.relation.referencesALEXANDRINO-DE-OLIVEIRA, P. et al. HIV/AIDS-associated visceral leishmaniasis in patients from an endemic area in Central-west Brazil. Memórias do Instituto Oswaldo Cruz, v. 105, n. 5, p. 692–697, ago. 2010. ANDERS, S.; PYL, P. T.; HUBER, W. HTSeq—a Python framework to work with high-throughput sequencing data. Bioinformatics, v. 31, n. 2, p. 166–169, 15 jan. 2015. BLACKWELL, J. M.; FAKIOLA, M.; SINGH, O. P. Genetics, Transcriptomics and Meta-Taxonomics in Visceral Leishmaniasis. Frontiers in Cellular and Infection Microbiology, v. 10, 25 nov. 2020. BRASIL. Manual de Vigilância e Controle da Leishmaniose Visceral. 1a ed. Brasília-DF: Ministério da Saúde, 2014. v. I BRASIL. Situação Epidemiológica da Leishmaniose Visceral. Disponível em: <https://www.gov.br/saude/pt-br/assuntos/saude-de-a-a-z/l/leishmaniose-visceral/situacao-epidemiologica-da-leishmaniose-visceral>. Acesso em: 30 ago. 2022. BUCCITELLI, C.; SELBACH, M. mRNAs, proteins and the emerging principles of gene expression control. Nature Reviews Genetics, v. 21, n. 10, p. 630–644, 24 out. 2020. BURZA, S. et al. Risk Factors for Visceral Leishmaniasis Relapse in Immunocompetent Patients following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, India. PLoS Neglected Tropical Diseases, v. 8, n. 1, p. e2536, 2 jan. 2014. BURZA, S.; CROFT, S. L.; BOELAERT, M. Leishmaniasis. The LancetLancet Publishing Group, , 15 set. 2018. CALDAS, A. et al. Balance of IL-10 and interferon-γ plasma levels in human visceral leishmaniasis: Implications in the pathogenesis. BMC Infectious Diseases, v. 5, n. 1, p. 1–9, 19 dez. 2005. CAMPOS, M. A. G. et al. Is splenectomy an option for multiple relapses in a child with visceral leishmaniasis? A case report. Revista da Sociedade Brasileira de Medicina Tropical, v. 54, 2021. CARRIÓN, J. et al. Immunohistological features of visceral leishmaniasis in BALB/c mice. Parasite Immunology, v. 28, n. 5, p. 173–183, 10 maio 2006. CESTA, M. F. Normal Structure, Function, and Histology of the Spleen. Toxicologic Pathology, v. 34, n. 5, p. 455–465, 25 ago. 2006. CHADBURN, A. The spleen: Anatomy and anatomical function. Seminars in Hematology, v. 37, p. 13–21, jan. 2000. 66 CHOWDHURY, B. P. et al. Immunomodulation of host-protective immune response by regulating Foxp3 expression and Treg function in Leishmania- infected BALB/c mice: critical role of IRF1. Pathogens and Disease, v. 73, n. 8, p. ftv063, nov. 2015. COSTA, A. S. A. et al. Cytokines and visceral leishmaniasis: a comparison of plasma cytokine profiles between the clinical forms of visceral leishmaniasis. Memórias do Instituto Oswaldo Cruz, v. 107, n. 6, p. 735–739, set. 2012. COSTA, C. H. N. et al. Is severe visceral leishmaniasis a systemic inflammatory response syndrome? A case control study. Revista da Sociedade Brasileira de Medicina Tropical, v. 43, n. 4, p. 386–392, 2010. COSTA-MADEIRA, J. C. et al. T Lymphocyte Exhaustion During Human and Experimental Visceral Leishmaniasis. Frontiers in Immunology, v. 13, 2 maio 2022. CRETNEY, E. et al. The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nature Immunology, v. 12, n. 4, p. 304–311, 6 abr. 2011. DA SILVA SANTANA CRUZ, C. et al. Factors associated with human visceral leishmaniasis cases during urban epidemics in Brazil: A systematic review. ParasitologyCambridge University Press, , 1 maio 2021. DA SILVA, T. A. M. et al. Prognostic factors associated with death from visceral leishmaniasis: a case-control study in Brazil. Transactions of The Royal Society of Tropical Medicine and Hygiene, v. 114, n. 5, p. 346–354, 7 maio 2020. DAVID SIBLEY, L. Invasion and intracellular survival by protozoan parasites. Immunological Reviews, v. 240, n. 1, p. 72–91, mar. 2011. DAYAKAR, A. et al. Cytokines: Key determinants of resistance or disease progression in visceral leishmaniasis: Opportunities for novel diagnostics and immunotherapy. Frontiers in ImmunologyFrontiers Media S.A., , 2019. DE ARAÚJO, V. E. M. et al. Early Clinical Manifestations Associated with Death from Visceral Leishmaniasis. PLoS Neglected Tropical Diseases, v. 6, n. 2, p. e1511, 7 fev. 2012. DE MELO, C. V. B. et al. Splenic Transcriptional Responses in Severe Visceral Leishmaniasis: Impaired Leukocyte Chemotaxis and Cell Cycle Arrest. Frontiers in Immunology, v. 12, 5 nov. 2021. DE SOUZA, T. L. et al. Pro-Cellular Exhaustion Markers are Associated with Splenic Microarchitecture Disorganization and Parasite Load in Dogs with Visceral Leishmaniasis. Scientific Reports, v. 9, n. 1, 1 dez. 2019. DEAK, E. et al. Murine visceral leishmaniasis: IgM and polyclonal B‐cell activation lead to disease exacerbation. European Journal of Immunology, v. 40, n. 5, p. 1355–1368, 29 maio 2010. 67 DOBIN, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics, v. 29, n. 1, p. 15–21, 1 jan. 2013. DOS SANTOS, P. L. et al. The Severity of Visceral Leishmaniasis Correlates with Elevated Levels of Serum IL-6, IL-27 and sCD14. PLOS Neglected Tropical Diseases, v. 10, n. 1, p. e0004375, 27 jan. 2016. DOS-SANTOS, W. L. et al. A case of conventional treatment failure in visceral leishmaniasis: leukocyte distribution and cytokine expression in splenic compartments. BMC Infectious Diseases, v. 14, n. 1, p. 491, 9 dez. 2014. DUTRA, R. A. et al. Splenectomy in a patient with treatment-resistant visceral leishmaniasis: a case report. Revista da Sociedade Brasileira de Medicina Tropical, v. 45, n. 1, p. 130–131, fev. 2012. ENDRIS, M. et al. Characteristics of bacterial sepsis among patients with visceral leishmaniasis. Asian Pacific Journal of Tropical Biomedicine, v. 4, n. 11, p. 871–875, nov. 2014. FERNÁNDEZ-GUERRERO, M. L. et al. Visceral leishmaniasis in immunocompromised patients with and without AIDS: a comparison of clinical features and prognosis. Acta Tropica, v. 90, n. 1, p. 11–16, mar. 2004. FU, S.-H. et al. New insights into Blimp-1 in T lymphocytes: a divergent regulator of cell destiny and effector function. Journal of Biomedical Science, v. 24, n. 1, p. 49, 21 dez. 2017. GARG, R. et al. Leishmania infantum amastigotes enhance HIV-1 production in cocultures of human dendritic cells and CD4 T cells by inducing secretion of IL-6 and TNF-alpha. PLoS neglected tropical diseases, v. 3, n. 5, 2009. GHOSH, S. et al. Cytokines in the generation and function of regulatory T cell subsets in leishmaniasis. Cytokine, v. 147, p. 155266, nov. 2021. GOODMAN, J. C. et al. Pro-inflammatory and pro-apoptotic elements of the neuroinflammatory response are activated in traumatic brain injury. Em: [s.l: s.n.]. p. 437–439. GORSKI, S. et al. Visceral Leishmaniasis Relapse in Southern Sudan (1999–2007): A Retrospective Study of Risk Factors and Trends. PLoS Neglected Tropical Diseases, v. 4, n. 6, p. e705, 8 jun. 2010. GOTO, Y. et al. Short report: Elevation of serum B-cell activating factor levels during visceral leishmaniasis. American Journal of Tropical Medicine and Hygiene, v. 91, n. 5, p. 912–914, 2014. GUEDESID, D. L. et al. Comparison of serum cytokine levels in symptomatic and asymptomatic HIV-Leishmania coinfected individuals from a Brazilian visceral leishmaniasis endemic area. PLOS Neglected Tropical Diseases, v. 16, n. 6, p. e0010542, 1 jun. 2022. 68 HAILU, A. et al. ELEVATED PLASMA LEVELS OF INTERFERON (IFN)-, IFN-INDUCING CYTOKINES, AND IFN-INDUCIBLE CXC CHEMOKINES IN VISCERAL LEISHMANIASIS. [s.l: s.n.]. HENN, G. A. DE L. et al. Is Visceral Leishmaniasis the same in HIV-coinfected adults? Brazilian Journal of Infectious Diseases, v. 22, n. 2, p. 92–98, 1 mar. 2018. HERMIDA, M. D. E. R. et al. Histological Disorganization of Spleen Compartments and Severe Visceral Leishmaniasis. Frontiers in cellular and infection microbiology, v. 8, n. November, p. 394, 2018. KRAUS, M. D. Splenic histology and histopathology: An update. Seminars in Diagnostic Pathology, v. 20, n. 2, p. 84–93, 2003. KUMAR, P. et al. Prophylactic interferon-γ and interleukin-17 facilitate parasite clearance in experimental visceral leishmaniasis. Tropical Parasitology, v. 9, n. 1, p. 30, 1 jan. 2019. KUROTAKI, D.; UEDE, T.; TAMURA, T. Functions and development of red pulp macrophages. Microbiology and Immunology, v. 59, n. 2, p. 55–62, fev. 2015. LAURENTI, M. D. et al. Asymptomatic dogs are highly competent to transmit Leishmania (Leishmania) infantum chagasi to the natural vector. Veterinary Parasitology, v. 196, n. 3–4, p. 296–300, set. 2013. LEKIC, N. et al. Splenectomy for Visceral Leishmaniasis Out of an Endemic Region: A Case Report and Literature Review. Medicina, v. 58, n. 2, p. 184, 26 jan. 2022. LEWIS, S. M.; WILLIAMS, A.; EISENBARTH, S. C. Structure and function of the immune system in the spleen. Science Immunology, v. 4, n. 33, 22 mar. 2019. LIMA, I. S. et al. Severe clinical presentation of visceral leishmaniasis in naturally infected dogs with disruption of the splenic white pulp. PLoS ONE, v. 9, n. 2, 2014. LINDOSO, J. A. L. et al. Visceral leishmaniasis and HIV coinfection: current perspectives. HIV/AIDS (Auckland, N.Z.), v. 10, p. 193, 2018. LIU, R. et al. IL-17 Promotes Neutrophil-Mediated Immunity by Activating Microvascular Pericytes and Not Endothelium. The Journal of Immunology, v. 197, n. 6, p. 2400–2408, 15 set. 2016. LONSDALE, J. et al. The Genotype-Tissue Expression (GTEx) project. Nature Genetics, v. 45, n. 6, p. 580–585, 29 jun. 2013. MACLENNAN, I. C. M. Germinal Centers. Annual Review of Immunology, v. 12, n. 1, p. 117–139, abr. 1994. MAIA, C. et al. Experimental Transmission of Leishmania infantum by Two Major Vectors: A Comparison between a Viscerotropic and a Dermotropic Strain. PLoS Neglected Tropical Diseases, v. 5, n. 6, p. e1181, 14 jun. 2011. 69 MAKSOUD, S. et al. Leishmania donovani and HIV co-infection in vitro: Identification and characterization of main molecular players. Acta Tropica, v. 228, p. 106248, 1 abr. 2022. MANNAN, S. BIN et al. Prevalence and associated factors of asymptomatic leishmaniasis: a systematic review and meta-analysis. Parasitology International, v. 81, p. 102229, abr. 2021. MARCO ANTÔNIO CARDOSO DE ALMEIDA. Caracterização histopatológica de casos fatais de Leishmaniose Visceral Humana: Estudo caso-controle de Necropsias. Tese (Doutorado)—Salvador: Universidade Federal da Bahia, 2019. MARIE, J. C. et al. TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. The Journal of Experimental Medicine, v. 201, n. 7, p. 1061–1067, 4 abr. 2005. MAURYA, R. et al. Brief Definitive Report: Human visceral leishmaniasis is not associated with expansion or accumulation of Foxp3+ CD4 cells in blood or spleen. Parasite Immunology, v. 32, n. 7, p. 479–483, 19 mar. 2010. MCKENZIE, C. V. et al. Splenomegaly: Pathophysiological bases and therapeutic options. The International Journal of Biochemistry & Cell Biology, v. 94, p. 40–43, jan. 2018. MEBIUS, R. E.; KRAAL, G. Structure and function of the spleen. Nature Reviews Immunology, ago. 2005. MEDRANO, F. J. et al. Dynamics of serum cytokines in patients with visceral leishmaniasis and HIV-1 co-infection. Clinical and Experimental Immunology, v. 114, n. 3, p. 403–407, 25 dez. 2001. MELO, C. V. B. DE et al. Phenotypical Characterization of Spleen Remodeling in Murine Experimental Visceral Leishmaniasis. Frontiers in Immunology, v. 11, n. April, p. 1–13, 2020. MICHALICK, M. S. M.; RIBEIRO, R. R.; DA SILVA, S. M. Leishmaniose Visceral Americana. Em: NEVES, D. P. (Ed.). Parasitologia Humana. 13. ed. São Paulo: Atheneu, 2016. v. Ip. 69–90. MONTES DE OCA, M.; ENGWERDA, C. R.; KAYE, P. M. Cytokines and splenic remodelling during Leishmania donovani infection. Cytokine: X, v. 2, n. 4, p. 100036, dez. 2020. MOULIK, S. et al. Status of IL-4 and IL-10 driven markers in experimental models of Visceral Leishmaniasis. Parasite Immunology, v. 43, n. 1, p. e12783, 1 jan. 2021. NAGELKERKE, S. Q. et al. Red pulp macrophages in the human spleen are a distinct cell population with a unique expression of Fc-γ receptors. Blood Advances, v. 2, n. 8, p. 941–953, 24 abr. 2018. NASCIMENTO, E. T. et al. The emergence of concurrent HIV-1/AIDS and visceral leishmaniasis in Northeast Brazil. Transactions of the Royal Society of Tropical Medicine and Hygiene, v. 105, n. 5, p. 298–300, maio 2011. 70 NYLÉN, S. et al. Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis. Journal of Experimental Medicine, v. 204, n. 4, p. 805–817, 16 abr. 2007. OHL, L. et al. Chemokines as organizers of primary and secondary lymphoid organs. Seminars in Immunology, v. 15, n. 5, p. 249–255, out. 2003. OMACHI, S. et al. B-cell activating factor deficiency suppresses splenomegaly during Leishmania donovani infection. Biochemical and Biophysical Research Communications, v. 489, n. 4, p. 528–533, 2017. PELISSARI, D. M. et al. Tratamento da Leishmaniose Visceral e Leishmaniose Tegumentar Americana no Brasil. Epidemiologia e Serviços de Saúde, v. 20, n. 1, p. 107–110, mar. 2011. PEREZ, O. A. et al. CD169 + macrophages orchestrate innate immune responses by regulating bacterial localization in the spleen. Science Immunology, v. 2, n. 16, 13 out. 2017. PINTADO, V. et al. Visceral Leishmaniasis in Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected Patients: A Comparative Study. Medicine, v. 80, n. 1, 2001. PRATA, A.; SILVA, L. A. Calazar. Em: COURA, J. R. (Ed.). Dinâmica das Doenças Infecciosas e Parasitárias. Rio de Janeiro: Guanabara Koogan, 2005. v. Ip. 713–732. QUEIROZ, M. J. A.; ALVES, J. G. B.; CORREIA, J. B. Leishmaniose visceral: características clínico-epidemiológicas em crianças de área endêmica. Jornal de Pediatria, v. 80, n. 2, p. 141–146, abr. 2004. RAI, A. K. et al. Regulatory T cells suppress T cell activation at the pathologic site of human visceral leishmaniasis. PLoS ONE, v. 7, n. 2, 8 fev. 2012. REBOUÇAS, A. et al. Leishmania-Induced Dendritic Cell Migration and Its Potential Contribution to Parasite Dissemination. Microorganisms, v. 9, n. 6, p. 1268, 11 jun. 2021. REDMOND, H. P. et al. Surgical anatomy of the human spleen. British Journal of Surgery, v. 76, n. 2, p. 198–201, 7 dez. 2005. REINALDO, L. G. C. et al. Splenectomy in Patients with Visceral Leishmaniasis Resistant to Conventional Therapy and Secondary Prophylaxis: A Retrospective Cohort. The American Journal of Tropical Medicine and Hygiene, v. 107, n. 2, p. 342–348, 17 ago. 2022. REIS, L. L. DOS et al. Changes in the epidemiology of visceral leishmaniasis in Brazil from 2001 to 2014. Revista da Sociedade Brasileira de Medicina Tropical, v. 50, n. 5, set. 2017. RIBEIRO-GOMES, F. L.; SACKS, D. The influence of early neutrophil-Leishmania interactions on the host immune response to infection. Frontiers in cellular and infection microbiology, 2012. 71 ROCHA, M. I. et al. Leishmania infantum Enhances Migration of Macrophages via a Phosphoinositide 3-Kinase Î-Dependent Pathway. ACS Infectious Diseases, v. 6, n. 7, p. 1643–1649, 10 jul. 2020. ROGERS, M. E.; CHANCE, M. L.; BATES, P. A. The role of promastigote secretory gel in the origin and transmission of the infective stage of Leishmania mexicana by the sandfly Lutzomyia longipalpis. Parasitology, v. 124, n. 5, p. 495–507, 5 maio 2002. ROMANO, A. et al. Interferon-γ-Producing CD4+ T Cells Drive Monocyte Activation in the Bone Marrow During Experimental Leishmania donovani Infection. Frontiers in Immunology, v. 12, 7 set. 2021. SAMANT, M. et al. Role of Cytokines in Experimental and Human Visceral Leishmaniasis. Frontiers in Cellular and Infection Microbiology, v. 11, 18 fev. 2021a. SAMANT, M. et al. Role of Cytokines in Experimental and Human Visceral Leishmaniasis. Frontiers in Cellular and Infection Microbiology, v. 11, 18 fev. 2021b. SANTANA, C. C. et al. Inflammation and structural changes of splenic lymphoid tissue in visceral leishmaniasis: A study on naturally infected dogs. Parasite Immunology, v. 30, n. 10, p. 515–524, 2008. SAPORITO, L. et al. Visceral leishmaniasis: host–parasite interactions and clinical presentation in the immunocompetent and in the immunocompromised host. International Journal of Infectious Diseases, v. 17, n. 8, p. e572–e576, ago. 2013. SHARMA, U.; SINGH, S. Insect vectors of Leishmania: distribution, physiology and their controlJ Vector Borne Dis. [s.l: s.n.]. SILVA, J. S. et al. Low CXCL13 expression, splenic lymphoid tissue atrophy and germinal center disruption in severe canine visceral leishmaniasis. PLoS ONE, 2012. SILVA-BARRIOS, S.; CHARPENTIER, T.; STÄGER, S. The Deadly Dance of B Cells with Trypanosomatids. Trends in Parasitology, v. 34, n. 2, p. 155–171, 2018. SILVA-O’HARE, J. et al. Disruption of splenic lymphoid tissue and plasmacytosis in canine visceral leishmaniasis: Changes in homing and survival of plasma cells. PLoS ONE, v. 11, n. 5, p. 1–17, 2016. SINGH, N. et al. Peripheral Blood Monocytes With an Antiinflammatory Phenotype Display Limited Phagocytosis and Oxidative Burst in Patients With Visceral Leishmaniasis. The Journal of Infectious Diseases, v. 218, n. 7, 24 ago. 2018. SMEDLEY, D. et al. BioMart – biological queries made easy. BMC Genomics, v. 10, n. 1, p. 22, 14 dez. 2009. SMELT, S. C. et al. Destruction of follicular dendritic cells during chronic visceral leishmaniasis. Journal of immunology (Baltimore, Md. : 1950), v. 158, n. 8, p. 3813–21, 15 abr. 1997. 72 STEINIGER, B.; RÜTTINGER, L.; BARTH, P. J. The Three-dimensional Structure of Human Splenic White Pulp Compartments. Journal of Histochemistry & Cytochemistry, v. 51, n. 5, p. 655–663, 26 maio 2003. STEINIGER, B. S. Human spleen microanatomy: Why mice do not suffice. Immunology, v. 145, n. 3, p. 334–346, 2015. STINGL, J. et al. Morphology and some biomechanical properties of human liver and spleen. Surgical and Radiologic Anatomy, v. 24, n. 5, p. 285–289, dez. 2002. TAKELE, Y. et al. Immunological factors, but not clinical features, predict visceral leishmaniasis relapse in patients co-infected with HIV. Cell Reports Medicine, v. 3, n. 1, p. 100487, jan. 2022a. TAKELE, Y. et al. Immunological factors, but not clinical features, predict visceral leishmaniasis relapse in patients co-infected with HIV. Cell Reports Medicine, v. 3, n. 1, p. 100487, 18 jan. 2022b. VALLEJO, A. et al. High levels of CD4+ CTLA-4+ Treg cells and CCR5 density in HIV-1-infected patients with visceral leishmaniasis. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, v. 34, n. 2, p. 267–275, 1 fev. 2015. VARMA, N.; NASEEM, S. Hematologic Changes in Visceral Leishmaniasis/Kala Azar. Indian Journal of Hematology and Blood Transfusion 2010 26:3, v. 26, n. 3, p. 78–82, 30 set. 2010. VERBOOGEN, D. R. J. et al. Interleukin-6 secretion is limited by self-signaling in endosomes. Journal of Molecular Cell Biology, v. 11, n. 2, p. 144–157, 1 fev. 2019. VERESS, B. et al. Morphology of the spleen and lymph nodes in fatal visceral leishmaniasis. Immunology, v. 33, n. 5, p. 605–10, nov. 1977. VIANA, A. G. et al. Infection of Human Monocytes with Leishmania infantum Strains Induces a Downmodulated Response when Compared with Infection with Leishmania braziliensis. Frontiers in Immunology, v. 8, 8 jan. 2018. VOLPEDO, G. et al. Determinants of Innate Immunity in Visceral Leishmaniasis and Their Implication in Vaccine Development. Frontiers in ImmunologyFrontiers Media S.A., , 12 out. 2021. VOLPIN, G. et al. Cytokine levels (IL-4, IL-6, IL-8 and TGFβ) as potential biomarkers of systemic inflammatory response in trauma patients. International Orthopaedics, v. 38, n. 6, p. 1303–1309, 2014. WORLD HEALTH ORGANIZATION. Leishmaniasis.pt_BR
dc.type.degreeDoutoradopt_BR
Aparece nas coleções:Tese (PGPAT)

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
Jonathan Luís Magalhães Fontes Tese final.pdf8,53 MBAdobe PDFVisualizar/Abrir
Mostrar registro simples do item Visualizar estatísticas


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.